Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
Add more filters










Publication year range
1.
Crit Rev Food Sci Nutr ; : 1-19, 2023 Jan 19.
Article in English | MEDLINE | ID: mdl-36655428

ABSTRACT

Lycopene is a promising biological functional component with various biological activities and excellent pharmacological activities. However, its low water solubility and stability lead to low oral bioavailability, which limits its edible and medicinal research. Then, it is necessary to explore effective methods to protect lycopene from destruction and further exploit its potential benefits. The absorption of lycopene in vivo is affected by solubility, stability, isomer type, emulsifying ability, difficulty in forming micelles in vivo, and interaction with food components. Emulsions, pickering emulsions, micelles, liposomes, bigels, beasds, solid dispersions, microcapsules, nanoparticles, electrospinning and other drug delivery systems can be used as good strategies to improve the stability and bioavailability of lycopene. In this paper, the absorption process of lycopene in vivo and the factors affecting its bioavailability were discussed, and the preparation strategies for improving the stability, bioavailability, and health benefits of lycopene were reviewed, to provide some clues and references for the full utilization of lycopene in the field of health. However, there are still various unresolved mysteries regarding the metabolism of lycopene. The safety and in vivo studies of various preparations should be further explored, and the above technologies also face the challenge of industrial production.

2.
Drug Deliv Transl Res ; 13(1): 9-17, 2023 01.
Article in English | MEDLINE | ID: mdl-35661106

ABSTRACT

In this study, a new gastro-floating sustained-release capsule (GFC) with levodopa (LD) and benserazide hydrochloride (BH) was successfully developed. GFCs were prepared by filling the LD and BH granules into hard capsules and coated with cellulose acetate (CA) solution as a controlled-release layer. The effects of formulation factors on the release of GFCs were conducted. The AUC0~24 (µg h/mL) of LD were 69.31 ± 3.61 (µg h/mL) and 28.87 ± 2.58 (µg h/mL) and the Cmax were 7.84 ± 0.34 (µg/mL) and 9.21 ± 1.04 (µg/mL) in the GFCs and commercial tablets respectively. The relative bioavailability of LD was 267.55 ± 34.54%. Compared with commercial tablets, the pharmacokinetic study indicated that the developed GFCs provided a better sustained-release effect and higher bioavailability than commercial tablets.


Subject(s)
Levodopa , Delayed-Action Preparations
3.
Food Chem ; 405(Pt A): 134799, 2023 Mar 30.
Article in English | MEDLINE | ID: mdl-36347202

ABSTRACT

Lycopene, a popular antioxidant, exists abundantly in nature in all-E form, but the Z-lycopene has better solubility and absorption characteristics. Lycopene is labile to light, thermal and oxygen. Emerging technological approaches are developed to improve the stability of lycopene during production and processing. This review presents the degradation mechanism of lycopene. A comprehensive evaluation has made by comparing the advantages and disadvantages of different extraction and isomerization methods. Encapsulation of lycopene in different delivery systems can further improve its stability. The process and formulation influence factors, as well as the advantages and disadvantages of lycopene encapsulation delivery systems are summarized. In the future, it is necessary to scientifically design low-cost and high-efficiency lycopene production methods.The stable and high bioavailable lycopene encapsulation systems need to be designed. Further study on the chemical stability mechanism of lycopene, the toxicity of biological materials, the safety of lycopene preparations also need to be evaluated.


Subject(s)
Carotenoids , Solanum lycopersicum , Lycopene , Antioxidants , Chemical Phenomena
4.
J Control Release ; 352: 946-960, 2022 12.
Article in English | MEDLINE | ID: mdl-36375618

ABSTRACT

Arthritis is a kind of chronic disease that affects joints and muscles with the symptoms of joint pain, inflammation and limited movement of joints. Among various clinical therapies, drug therapy has been extensively applied because of its accessibility, safety and effectiveness. In recent years, the intra-articular injection has dramatic therapeutic effects in treating arthritis with high patient compliance and low side effects. In this review, we will introduce pathology of arthritis, along with the accessible treatment and diagnosis methods, then we will summarize major advances of current hopeful intra-articular delivery systems such as microspheres, hydrogels, nanoparticles and liposomes. At last, some safety assessments in the preclinical work and the main challenges for the further development of intra-articular treatment were also discussed.


Subject(s)
Arthritis , Humans , Arthritis/drug therapy , Drug Delivery Systems , Injections, Intra-Articular , Microspheres , Inflammation/drug therapy
5.
Biomed Pharmacother ; 155: 113772, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36271554

ABSTRACT

The objective of this study was to explore an innovative sustained release technology and design a new microporous resin-based polymer device (RPD) for controlled release of glipizide (GZ). Photocurable resin was applied to prepare the resin layer to control GZ release. The impact of formulation parameters consisting of the type and amount of pore formers and pH modifiers, photocurable curing time as well as the weight of resin layer on GZ release were examined. The GZ-RPD was fabricated applying 24 mg of resin layer with PEG400 (100 % of the resin weight) as pore former and 10 mg of Na2CO3 as pH modifier. Scanning electron microscopy (SEM) demonstrated resin particles presenting a porous structure constituted the resin layer. The GZ-RPD possessed prolonged Tmax and reduced Cmax relative to commercial tablets. The relative bioavailability of the RPDs as well as commercial tablets was 93.65 % since the AUC0-24 h were 6111.05 ± 238.89 ng·h/mL and 6525.09 ± 760.59 ng h/mL, respectively. The release mechanism of the GZ-RPD was discussed. This paper provided an innovative concept to produce controlled GZ release oral formulation fabricated by photocurable resin, which demonstrated both excellent in vitro release and in vivo pharmacokinetics.


Subject(s)
Glipizide , Polymers , Glipizide/chemistry , Glipizide/pharmacokinetics , Delayed-Action Preparations/chemistry , Tablets , Excipients/chemistry
7.
Crit Rev Food Sci Nutr ; 62(12): 3370-3388, 2022.
Article in English | MEDLINE | ID: mdl-33393368

ABSTRACT

Freeze-drying technology is an interdisciplinary and complex technology, combined with freezing and vacuum drying, It has become an important technology for heat-sensitive drugs and food preservation. Freeze-dried foods are classified into meat, vegetables, fruits, fungus, and micro-powders, etc. In this paper, the definition, principle, steps, advantages and disadvantages of freeze-drying are summarized, and the research progress of freeze-drying in food industry in recent years is reviewed, including the technological parameters and influencing factors.


Subject(s)
Desiccation , Vegetables , Food Preservation , Freeze Drying , Technology
8.
Crit Rev Food Sci Nutr ; 62(10): 2627-2640, 2022.
Article in English | MEDLINE | ID: mdl-33320702

ABSTRACT

Due to special cavity structure, cyclodextrin can form inclusion complex with a large number of compounds, which can be widely used in food industry, such as enhancing antibacterial activity, extending the storage period of food, increasing the solubility of food ingredients, removing cholesterol in food and so on. In this paper, the formation mechanism, classification and properties of cyclodextrin inclusion complex were reviewed, and the applications of cyclodextrin and its derivatives in food industry were discussed.


Subject(s)
Cyclodextrins , Antioxidants/chemistry , Cyclodextrins/chemistry , Food Industry , Solubility
9.
Eur J Pharm Biopharm ; 163: 102-108, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33819628

ABSTRACT

The aim of this study was to formulate osmotic pump capsules (OPCs) to control the release of nifedipine (NP). NP solid dispersion was prepared by solvent evaporation method. The prepared mixture of NP solid dispersion and various excipients were filled into the commercial HPMC hard capsule shells and then coated with cellulose acetate (CA) solution to form NP-OPC. The CA coating solution consisted of CA as semi-permeable membrane, and Poloxamer 188 as pore formers. The impact of addition agents, citric acid and pore formers on in vitro drug release were investigated. Furthermore, the study has highlighted the impact of paddle speed and the pH value of release media, on the release and compared the release with the commercial controlled release tablets. The in vitro drug release study indicated that drug release could reach 95% in 24 h with optimal formulation, and interestingly model fitting showed that the drug release behavior was closely followed to zero-order release kinetics. The pharmacokinetic studies were performed in rabbits with commercial controlled release tablets as reference, both preparations showed a sustained release effect. Compared with traditional preparation methods of OPCs, the new preparation process was simplified without the operation of laser drilling and the sealing process of capsule body and cap, which improved the feasibility of industrial production.


Subject(s)
Excipients/chemistry , Nifedipine/pharmacokinetics , Poloxamer/chemistry , Animals , Capsules , Cellulose/analogs & derivatives , Cellulose/chemistry , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/pharmacokinetics , Drug Evaluation, Preclinical , Drug Liberation , Hydrogen-Ion Concentration , Nifedipine/administration & dosage , Osmotic Pressure , Rabbits , Solubility , Tablets
10.
J Agric Food Chem ; 69(10): 2936-2949, 2021 Mar 17.
Article in English | MEDLINE | ID: mdl-33683870

ABSTRACT

Nutraceuticals have been gradually accepted as food ingredients that can offer health benefits and provide protection against several diseases. It is widely accepted due to potential nutritional benefits, safety, and therapeutic effects. Most nutraceuticals are vulnerable to the changes in the external environment, which leads to poor physical and chemical stability and absorption. Several researchers have designed various encapsulation technologies to promote the use of nutraceuticals. Microfluidic technology is an emerging approach which can be used for nutraceutical delivery with precise control. The delivery systems using microfluidic technology have obtained much interest in recent years. In this review article, we have summarized the recently introduced nutraceutical delivery platforms including emulsions, liposomes, microspheres, microgels, and polymer nanoparticles based on microfluidic techniques. Emphasis has been made to discuss the advantages, preparations, characterizations, and applications of nutraceutical delivery systems. Finally, the challenges, several up-scaling methods, and future expectations are discussed.


Subject(s)
Dietary Supplements , Microfluidics , Delayed-Action Preparations , Emulsions , Liposomes
11.
Food Funct ; 12(5): 1933-1953, 2021 Mar 15.
Article in English | MEDLINE | ID: mdl-33596279

ABSTRACT

In the modern food industry, people are paying more and more attention to the use of edible nanoemulsions to encapsulate, protect and deliver lipophilic functional ingredients, such as volatile additives, polyphenols, aromas, pigments, proteins, vitamins, oil-soluble flavors, preservatives, etc., which are the current global needs. Nanoemulsions are constructed with droplets of nano range size and they offer many potential advantages over conventional emulsions including the delivery of both hydrophilic and hydrophobic compounds, higher stability, better antibacterial properties, good taste experience, higher affinity, longer shelf-life and improvement of the bioavailability of components. Moreover, they are highly capable of improving the wettability and/or solubility of poorly water-soluble compounds, which may result in better pharmacokinetic and pharmacodynamic properties of nutraceutical compounds. On the other hand, oral nanoemulsions also have certain risks, such as their ability to change the biological fate of biologically active ingredients in the gastrointestinal tract and the potential toxicity of certain ingredients used in their production. This review article summarizes the manufacturing, application, characterization, biological fate, potential toxicity, and future challenges and trends of nanoemulsions, and focuses on nanoemulsion-based nutraceutical delivery approaches suitable for the food industry.


Subject(s)
Dietary Supplements , Drug Delivery Systems/methods , Emulsions , Nanoparticles , Animals , Fish Oils , Humans , Hydrophobic and Hydrophilic Interactions , Mice , Plant Extracts , Rats , Solubility , Toxicity Tests
12.
Colloids Surf B Biointerfaces ; 189: 110833, 2020 May.
Article in English | MEDLINE | ID: mdl-32058254

ABSTRACT

The implimentation of newer technologies in drug delivery system have always been the focus of pharmaceutical scientists with advancement of technologies. In this investigation, a novel controlled-release drug-resin combination device (DRC) was designed using dental resin to control the release of dextromethorphan hydrobromide (DH). The influence of different factors on in-vitro drug release were investigated. A Box-Behnken design was used to select the optimized DRC formulation. The optimized DH loaded DRC (DH-DRC) was prepared using 59.88% of PEG400, 16 mg of dental resin and 6.64 mg of sodium chloride (NaCl). The DH releases at 2 h, 4 h and 8 h of the optimized formulation were significantly close to the predicted responses. The pharmacokinetic study in rabbits showed DH-DRC had prolonged tmax and apparently reduced Cmax compared with commercial tablets and the AUC0-24h of DH-DRC was slightly higher than commercial tablets. This study confirmed the novel DRC could control the release of drug. It concluded that DRC would be a promising and alternative approach for the development of controlled release dosage form.


Subject(s)
Composite Resins/chemistry , Dextromethorphan/chemistry , Animals , Dextromethorphan/blood , Drug Liberation , Particle Size , Rabbits , Surface Properties , Tablets/chemistry
13.
Curr Pharm Biotechnol ; 21(3): 180-193, 2020.
Article in English | MEDLINE | ID: mdl-31612824

ABSTRACT

Insulin (INS) therapy played a great role in patients with type 1 and type 2 diabetes to regulate blood glucose levels. Although hypodermic injection was commonly used for insulin delivery, it had some disadvantages such as pain, needle phobia and the risk of infection. Therefore, pulmonary insulin delivery had been developed as an alternative method to overcome the therapeutic challenges in recent years since pulmonary insulin administration showed great improvements in rapid action and circumvention of first-pass hepatic metabolism. This review described the most recent developments in pulmonary insulin administration. Firstly, the structure and physiology of the lung cavity were introduced. Next, the advantages and disadvantages of pulmonary administration were discussed. Then some new dosage forms for pulmonary insulin were investigated including carriers based on surfactants and carriers based on polymers. Finally, innovate insulin inhalers and formulations were also described.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Drug Delivery Systems/methods , Insulin/administration & dosage , Lung/metabolism , Administration, Inhalation , Diabetes Mellitus, Type 2/drug therapy , Drug Carriers/chemistry , Drug Compounding , Humans , Insulin/therapeutic use , Liver/metabolism
14.
Eur J Pharm Sci ; 143: 105165, 2020 Feb 15.
Article in English | MEDLINE | ID: mdl-31765810

ABSTRACT

The objective of the present study was to develop a novel long-acting intra-oral delivery system (LIDS) to overcome the frequent administration by the nonparenteral route with Huperzine A (HupA) as a model drug. HupA-LIDS was prepared using a magnetic drug delivery with dental resin as release controlling layer for long-term release of HupA. The factors that influenced the drug release comprised of the type and amount of pore formers, the speed of shaker, resin layer weight and drug loading. These factors were evaluated and optimized. The in-vitro release studies showed that the system was able to deliver HupA in an approximately zero-order kinetic. The SEM study showed that the multiple orifices on the surface of a resin layer formed due to presence of pore formers, which contributed to the HupA release. The pharmacokinetic study in rabbits demonstrated the HupA-LIDS could be released in vivo for more than 8 days with prolonged Tmax and significantly reduced Cmax in comparison with commercial tablets. This study provided some pioneering ideas for developing intra-oral extended release drug delivery system using dental resin as release controlling materials. The optimized HupA-LIDS can make excellent sustained release and have the potential for the long-acting product in the therapy of Alzheimer's disease.


Subject(s)
Alkaloids/administration & dosage , Cholinesterase Inhibitors/administration & dosage , Neuroprotective Agents/administration & dosage , Resins, Synthetic/administration & dosage , Sesquiterpenes/administration & dosage , Administration, Oral , Alkaloids/chemistry , Alkaloids/pharmacokinetics , Animals , Cholinesterase Inhibitors/pharmacokinetics , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacokinetics , Drug Liberation , Mouth Mucosa/metabolism , Neuroprotective Agents/pharmacokinetics , Rabbits , Resins, Synthetic/chemistry , Resins, Synthetic/pharmacokinetics , Sesquiterpenes/chemistry , Sesquiterpenes/pharmacokinetics , Tablets
15.
Eur J Drug Metab Pharmacokinet ; 45(1): 113-121, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31676984

ABSTRACT

BACKGROUND AND OBJECTIVES: Diabetes mellitus, a disease of glucose regulation, has become one of the most common medical problems in the world. At present, alternative therapy for diabetes has, to a large extent, been widely concerned with the improvement of treatment efficacy. The aims of this study were to characterize and evaluate the surface morphology of the novel glucose-responsive injectable microspheres containing insulin, along with their in vitro release and in vivo efficacy. METHODS: In this study, glucose-responsive microspheres as an emerging smart drug delivery system for controlled release of insulin were developed by an improved water-in-oil-in-water (W/O/W) double emulsion preparation method. Here, methoxypolyethylene glycol-hydrazone-4-methoxypolyethylene glycol benzoate (mPEG-Hz-mPEG4AB) was synthesized as a pH-responsive carrier. RESULTS: The microspheres had a good spherical structure with a particle size of 5 ~ 10 µm. Approximately 61% of insulin was released in 15 h under a high glucose environment but was barely released within the normal glucose range in in vitro studies. After a subcutaneous injection of insulin microspheres in rats, blood glucose levels rapidly decreased within 2 h and could be maintained for 2 days in the normal range. Histopathological evaluation indicated that the microspheres were almost non-irritating. CONCLUSIONS: The pH-responsive mPEG-Hz-mPEG4AB could be used as an efficient insulin microsphere carrier, and the optimized microspheres had good morphology and sustained hypoglycemic effect.


Subject(s)
Delayed-Action Preparations/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Drug Delivery Systems/methods , Hypoglycemic Agents/administration & dosage , Microspheres , A549 Cells , Animals , Blood Glucose , Cell Line , Diabetes Mellitus, Experimental/chemically induced , Drug Carriers/adverse effects , Drug Carriers/chemistry , Glucose , Humans , In Vitro Techniques , Injections, Subcutaneous , Insulin , Male , Models, Animal , Rats
16.
Eur J Pharm Sci ; 142: 105108, 2020 Jan 15.
Article in English | MEDLINE | ID: mdl-31669391

ABSTRACT

In this study, novel orally disintegrating tablets (ODTs) with multi-channel structure were designed to provide a rapid disintegration and subsequently drug dissolution. The ODTs were prepared using conventional wet compression through perforating channels with a special multi-channel mold. A modified sieve method was used in disintegration test as a quick screening tool during formulation evaluation. Moreover, physical properties, in vitro and in vivo disintegration time, dissolution rate and mouthfeel were also evaluated. The results demonstrated that developed multi-channel ODTs had good physical parameters, in vitro/in vivo correlation (IVIVC) of disintegration time and acceptable mouthfeel and dissolution. It also revealed that the presence of channels could accelerate the disintegration of ODTs because the channels could shorten the distance of water penetration and increased the specific surface area, resulting in a significant reduction in disintegration time. Above all, the introduction of novel multi-channel ODTs provided an alternative preparation method for ODTs and achieved good disintegration characteristics.


Subject(s)
Tablets/chemistry , Administration, Oral , Drug Compounding/methods , Drug Liberation/drug effects , Excipients/chemistry , Solubility/drug effects
17.
Front Chem ; 7: 80, 2019.
Article in English | MEDLINE | ID: mdl-30891440

ABSTRACT

A systematic chemical exploration of the marine-derived fungus Penicillium janthinellum led to the isolation of four indole-diterpenoid derivatives (1-4), including new penijanthines C and D (1 and 2), and a pair of new steroidal epimers, penijanthoids A and B (5 and 6). The calculated ECD spectra and Snatzke's method for the new compound 1 were carried out to determine its absolute configuration. The absolute configuration of 3 was established by X-ray diffraction and calculated ECD methods for the first time. DP4plus approach was used to elucidate the absolute configurations of the C-25 epimeric steroids 5 and 6. 25-Epimeric 5 and 6 represent the first examples of steroids forming a five-membered lactone between C-23 and C-27 from marine fungi. Compounds 1, 2, 5, and 6 displayed significant anti-Vibrio activity (Minimum inhibitory concentration, MIC values ranging from 3.1 to 50.0 µM) against three pathogenic Vibrio spp.

18.
Nat Prod Res ; 33(15): 2192-2199, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30445830

ABSTRACT

Citrinin dimeric derivatives are bioactive polyketides previously reported from Penicillium, Aspergillus and Monascus fungi species. Due to the large distance between the stereogenic centers of the two monomer units, it was difficult to determine the absolute configuration of the whole molecule (1). In previous work, the absolute configuration of 1 was just proposed by biogenetic considerations. To address this problem, the experimental VCD of 1 was compared with the corresponding DFT calculations for two diastereomers (1a and 1b). Also, the experimental ECD and NMR spectra of 1 were combined for analysis with the corresponding theoretical predictions for different diastereomers. Additionally, compound 1 showed promising anti-Vibrio activity against pathogenic Vibrio spp. with MIC values ranging from 0.4 to 0.8 µM.


Subject(s)
Circular Dichroism/methods , Citrinin/chemistry , Magnetic Resonance Spectroscopy/methods , Vibrio/chemistry , Citrinin/isolation & purification , Dimerization , Stereoisomerism
19.
Curr Pharm Biotechnol ; 19(9): 742-753, 2018.
Article in English | MEDLINE | ID: mdl-30227816

ABSTRACT

Diabetes mellitus is a chronic metabolic health condition affecting the steady state of blood sugar level. The usual method of administration is subcutaneous injection of insulin. There are several ways to subcutaneously inject insulin, such as syringes, insulin pens, and insulin pumps. However, subcutaneous injections of insulin can lead to discomfort, pain and local infection. This review focuses on traditional methods of insulin administration, non-invasive approaches, and new insulin therapy technologies, and the advantages and disadvantages of these approaches, as well as future development prospects are also discussed.


Subject(s)
Diabetes Mellitus/drug therapy , Drug Delivery Systems/methods , Hypoglycemic Agents/administration & dosage , Insulin/administration & dosage , Humans , Injections, Subcutaneous
20.
Sci Rep ; 8(1): 10621, 2018 Jul 13.
Article in English | MEDLINE | ID: mdl-30006520

ABSTRACT

Determination of the absolute configrations for natural products is one of the most important and challenging tasks, especially when the molecules display high conformational flexibility. In this paper, eight new prenylxanthones, aspergixanthones A-H (1-8), and one known analogue (9), were isolated from the marine-derived fungus Aspergillus sp. ZA-01. The absolute configurations of C-14 and C-15 in 1-8 were difficult to be assigned due to the high conformational flexibility of the chains. To solve this problem, the experimental ECD, ORD, and VCD spectra of 1 were combined for analysis with the corresponding theoretical predictions for its different diastereomers. This study suggested that a concerted application of more than one chiroptical methods could be used as a preferable approach for the stereochemical characterizations of flexible molecules. Compounds 1-9 were evaluated for their cytotoxic and antibacterial activities. Among them, 6 showed cytotoxicity against the A-549 cell line with the IC50 value of 1.1 µM, and 7 exhibited antibacterial activity against Micrococcus lysodeikticus with the MIC value of 0.78 µg/mL.


Subject(s)
Aquatic Organisms/chemistry , Aspergillus/chemistry , Biological Products/chemistry , Molecular Conformation , Xanthones/chemistry , A549 Cells , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/pharmacology , Biological Products/isolation & purification , Biological Products/pharmacology , Drug Screening Assays, Antitumor , Humans , Inhibitory Concentration 50 , Microbial Sensitivity Tests , Micrococcus/drug effects , Stereoisomerism , Xanthones/isolation & purification , Xanthones/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...